logo
15 Amazon Travel Essentials You Shouldn't Visit Europe Without This Summer, Starting at $3

15 Amazon Travel Essentials You Shouldn't Visit Europe Without This Summer, Starting at $3

When packing for Europe in the summer, most travelers immediately think of portable fans, travel adapters, and breezy linen clothes. Although these items should definitely have a spot in your suitcase, packing some easily forgotten—but just as necessary—travel essentials will make your trip even more enjoyable.
Last August, I visited Milan, and temperatures reached as high as 104 degrees Fahrenheit. As it turned out, many of the game-changing items were last-minute, unexpected essentials I packed in my bag, such as a thin summer shawl that provided coverage for visiting religious sites without weighing me down. You might have sudden rainstorms that call for a packable umbrella or drastic temperature changes that'll have you reaching for a lightweight cardigan. Here are 15 travel essentials that help me navigate European summer trips, plus items I'm planning to pack for my next getaway.
Picking the right comfortable sandals for a European summer city break is crucial because nothing kills the vibe faster than aching feet halfway through a stroll. After trying to conquer Milan in jelly sandals (a mistake I'll never repeat), a friend suggested this supportive pair from Cushionaire. Other customers agree, saying they've got proper arch support, real cushioning, and enough breathability for hot summer days. Bonus: they actually look cute! Keep in mind that, according to customers, they might run small, so consider ordering up a half size.
A cardigan for the summer? It may sound ridiculous, but trust me, this lightweight layer can be a total lifesaver. An early morning flight out of London—even during the summer—means traveling in the cold. And, believe it or not, Europe does have air conditioning, which can be quite an intense shift when moving between the outdoors into coach buses or stores. As someone who is very sensitive to AC, the cardigan I grabbed just before leaving for my flight amidst a heatwave became my most cherished item. Europe's weather is known to flip fast; one minute it's sunny, the next the breeze is too chilly. I was happy to have an optional top layer and will definitely be packing it for future summer trips.
An umbrella might just become your best travel buddy when exploring Europe. For example, I live in London, where we have short summers and sudden rain showers, meaning you'll be glad to have an umbrella with you at all times that's compact enough to fit into a small bag. I learned an umbrella can also be useful when it's sunny; I saw people using umbrellas to block the sun's harsh rays when out and about during a trip to Seoul, South Korea. I'm using this hack when exploring Europe this summer, too.
You know what comes in surprisingly handy at those charming old European markets? An old-school coin purse or a classic wallet. Although the world has embraced contactless payments, some markets still use cash. Having a coin purse while traveling means you're not fumbling with loose change. Plus, you'll likely need to pay a small fee to use public restrooms in Europe, especially at train stations—so this way, you'll have your coins ready! This Travelambo leather coin purse with its snap top closure has been praised by travelers for keeping money secure and easily accessible, so you can quickly fish out the exact change needed.
Crossbody bags are a travel essential, keeping your phone, cash, cards, passport, and SPF right at your fingertips without having to dig through a bulky backpack or tote bag. In busy cities or markets, it also adds a layer of security with a zipper closure. Wear it across your chest and keep an eye on your stuff, which is perfect in places where pickpocketing can, unfortunately, be an issue.
This Rungion crossbody bag is very similar to the one I typically bring on my trips to European cities in the summer. 'I just got back from a UK trip. This bag was invaluable to me during the airplane, terminal, shopping, and sightseeing on my trip,' one customer wrote. 'It is so easy to organize and keep everything safe. It is absolutely the BEST thing I bought for my traveling.' This lightweight bag is also washable, so it'll be easy to keep clean and looking like new.
Bear with me here—if your hotel offers a continental breakfast, it's not a bad idea to take a few pieces of fruit or some cookies with you for a quick snack later in the day. A collapsible Tupperware container is perfect for this; it keeps things from getting squashed in your bag while you're out and about. Just make sure not to pack anything perishable, and stick to items that can handle a few hours without refrigeration, like apples, crackers, or sealed pastries. Collapsible Tupperware like this will take up even less room in your bag when not in use.
I've always carried hand sanitizer bottles (even before COVID-19), but when I travel, especially on holiday, I try to limit how many liquids I pack to save space. That's where hand sanitizer wipes come in handy. They're so convenient, and they do more than just sanitize your hands: wipe down surfaces, clean off sticky fingers, or tackle any grime you pick up while exploring. Unlike liquid sanitizer, wipes won't leak in your bag, which means no surprise goo on your stuff.
A common European dress code rule that continues to catch tourists off guard during the summertime is the requirement to cover shoulders when visiting religious sites. During a walking tour of Milan last summer, which included the breathtaking Duomo, several women in my group were told they would be unable to enter because their shoulders were exposed. According to the dress code for the Duomo, both men and women must ensure their shoulders and knees are covered, meaning tank tops and shorts or skirts above the knee are not permitted. The only solution at the time for the people on my tour was to buy a paper-like poncho that they would dispose of later on. However, packing a thin summer shawl like this $11 one at Amazon will save you money in the long run since you'll actually use it again. And it's thin enough to tuck into your bag when your tour is over.
Perfect for soaking up excess oil and shine without smudging your makeup or leaving any residue behind, blotting sheets are an easy, lightweight essential that'll fit easily in any bag or pocket. Whether you're heading into a museum, grabbing a photo in front of a landmark, or sitting down at a café, a quick blot can have you looking fresh and feeling less sticky in seconds.
With so many European cities basking in strong sun and very little shade, a cap helps protect your scalp and face from the sun. Unlike a wide-brimmed hat, it's compact, easy to throw in your bag, and doesn't take up much space when you're not wearing it. It's also a great option if you're sensitive to air conditioning, like on trains, planes, or in overly cooled museums, since it gives your head a bit of cover without making you overheat.
Sometimes a European city break means sticking to a small budget and finding ways to stretch your budget to see as many cities or enjoy as many excursions as possible. This could mean opting for hostels or budget hotels with thin walls. Whether it's street noise from the late-night nearby party scene, hallway chatter, or your hostel bunkmate rustling around at 2 a.m., a good pair of noise-canceling earplugs can save your sleep and your sanity. Loop earplugs are praised for their effectiveness at blocking out sound and their reusability. They also have adjustable sizes to get the perfect fit, and they come in a convenient travel case.
I made the rookie mistake of choosing the cute sandals over the comfortable ones, and my feet paid the painful price. If you're anything like me on holiday, you'll be doing a ton of walking, often on cobbled streets and uneven sidewalks that look beautiful but aren't exactly foot-friendly. It's all part of the charm of exploring historic European cities, but trust me, your feet will feel it, especially if you packed the wrong shoes. These hydrocolloid bandages help speed the healing process along for scrapes, cuts, and blisters, and they take up very little space in your bag. When you need one, you'll be ridiculously glad you brought them, as I will be from now on.
Pocket-sized tissues might not seem like a big deal, but they're surprisingly handy on a summer trip through Europe. Between the heat, humidity, and all the walking, you're going to sweat, especially when you're hopping between cities or squeezing onto a packed metro train. I keep tissues in my pocket or bag to blot my face, dab away melting makeup, or just freshen up on the go throughout the day. Toss a pack in your bag and you'll thank yourself later.
Disposable cameras have a retro feel, which is why I love packing them for rustic cities. I recently bought this Fujifilm disposable camera because it lets me snap pictures without having to be glued to my phone. In iconic, historic cities with sunlit piazzas and vintage markets, I like that film cameras help capture the character of the city. With disposable cameras, you never know what the picture looks like until it's developed, a process which feels a bit like wandering the streets of an old European town, where every turn can lead to an unexpected little gem.
For those of us who like to wear makeup, this tinted moisturizer is lightweight and adds a dewy (but not sweaty-looking) finish to the skin, all while providing sun protection thanks to its SPF 30 formula. The regular-sized bottle is under 3.4 ounces and should be able to fit in your carry-on allowance. My skin easily dries out when traveling, and I wanted something that doesn't feel cakey or heavy, especially with lots of walking and hopping on and off polluted metro systems and buses. This moisturizer claims to improve the skin's hydration retention, soften the appearance of fine lines, and strengthen the skin barrier, which are all important features when dealing with sweat, the hot sun, and polluted city air that can do even more damage to our skin.
Love a great deal? Sign up for our T+L Recommends newsletter and we'll send you our favorite travel products each week.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Airline passenger sparks heated debate about 'rarely enforced' baggage policy on flight
Airline passenger sparks heated debate about 'rarely enforced' baggage policy on flight

Fox News

timean hour ago

  • Fox News

Airline passenger sparks heated debate about 'rarely enforced' baggage policy on flight

A flight passenger who boarded a late-night flight out of Atlanta, Georgia, shared frustrations about the baggage-related actions of some fellow flyers. Posting in the "r/delta" Reddit forum with the title, "Another rant about carry-ons and personal items," the user wrote to others, "Seriously, why have a 'rule' about one carry-on and one personal item when it's rarely enforced." The user added, "I watch[ed] a person with two, what I would call, large roll bags and no personal items put both rollers in an overhead bin while an FA [flight attendant] watched him do it." The user then added, "[Since] I paid to check my bag, I figured I'd put my backpack above my seat and the same FA [then] tells me that I can't do that." The person continued, "I mention to the FA that we just watched a person put two rollers in the overhead and why is that OK. The FA ignores me, moves on." The user said the flight attendant then put the bag under the seat in front. Reddit users took to the comments section to speculate about the actions of the traveler with two suitcases, plus bag policy habits. "Just from a personal experience, I once was asked about my two roller bags and my backpack as I was going to my seat," said one user. "I handle my mom's luggage when she gets on a plane because she can't. [So] it is very possible [this person was] doing the same." Another user pointed out other issues: "Let's talk about the real problem: baggage fees. This is why everyone uses a carry-on now. Which in turn makes boarding and deplaning take waaaay longer." Said yet another person, "Airlines need to start allowing a more generous checked baggage policy and start charging for carry-on luggage. That would solve several problems." One Redditor added, "I stopped traveling with a backpack because I got tired of having to sacrifice my legroom due to FAs screeching about backpacks going under the seat (even though it was usually my only carry-on)." One snarky user told the original poster, "Maybe you shouldn't be trying to police others, and [instead] should put your personal item under the seat in front of you where it [belongs]." "I'm [a member of a] flight crew who frequently travels as a passenger on commercial airliners," claimed one user. The person continued, "Rule of thumb is that if I'm not in uniform, I'm not allowed to bring more than the standard bag allowance for any passenger, whether crew or not." "If the flight is not full, oftentimes this rule is overlooked." Said another person on Reddit, "If I only have one item, that's my carry-on regardless of size, and I'm definitely putting it in the overhead and not under the seat in front of me." Former flight attendant and etiquette expert Jacqueline Whitmore of Florida told Fox News Digital the flight attendant may have been in the wrong in the case in question. "I'm not sure why this passenger was not allowed to put her backpack in the overhead bin. That's perfectly acceptable unless the bins are full," said Whitmore. She added, "The airlines have a policy that passengers can take one bag (of a certain size) and a personal item onboard the plane. If the flight is not full, oftentimes this rule is overlooked."

Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndrome
Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndrome

Associated Press

timean hour ago

  • Associated Press

Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndrome

Press release – No. 10 / 2025 Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndrome Copenhagen, Denmark, June 2, 2025 – Zealand Pharma A/S (Nasdaq: ZEAL) ('Zealand') (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for glepaglutide, a long-acting GLP-2 analog, for the treatment of adult patients with short bowel syndrome (SBS). The submission of the MAA to the EMA for glepaglutide administered twice weekly for the treatment of SBS is based on results from a pivotal Phase 3 trial (EASE-1), supported by interim results from two ongoing long-term extension trials (EASE-2 and EASE-3) and results from a mechanistic trial (EASE-4). 'We are pleased to bring our potential best-in-class GLP-2 analog, glepaglutide, one step closer to patients in Europe living with short bowel syndrome with intestinal failure, who urgently need more effective and more convenient treatment options,' said David Kendall, MD, Chief Medical Officer of Zealand Pharma. 'We believe that glepaglutide, administered twice weekly, offers meaningful potential to reduce both the burden of parenteral support and the inconvenience of daily dosing required with the only currently available GLP-2 therapy. Looking ahead, we expect to initiate the EASE-5 Phase 3 trial in the second half of the year to obtain further confirmatory safety and efficacy data on the twice weekly dosing regimen, supporting regulatory submission in the U.S.' About glepaglutide Glepaglutide is a long-acting GLP-2 analog in development as a potential treatment option for short bowel syndrome (SBS). Glepaglutide is developed as a liquid product in an autoinjector designed for subcutaneous administration by twice weekly dosing, aimed to reduce, or eliminate, the need for parenteral support in people living with SBS. The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for glepaglutide for the treatment of SBS. About the EASE Clinical Trial Program The Phase 3 program, named EASE, is designed to evaluate the potential for glepaglutide to reduce or eliminate the need for parenteral support in SBS patients with intestinal failure. EASE-1 (NCT03690206) was a randomized, double-blind Phase 3 trial that enrolled a total of 106 SBS patients with intestinal failure who were dependent on parenteral support for at least three days per week. Patients were evenly randomized to receive treatment with 10 mg glepaglutide administered either once or twice weekly, or placebo. The primary endpoint in the trial was the absolute change in weekly parenteral support volume from baseline at 24 weeks. At 24 weeks, glepaglutide administered twice weekly significantly reduced the total weekly volume of PS by 5.13 liters/week, compared to a reduction of 2.85 liters/week in the placebo group (p=0.0039). When administered once weekly, glepaglutide treatment resulted in a reduction in weekly PS of 3.13 liters/week, however this did not achieve statistical significance. A total of 9 patients treated with glepaglutide were completely weaned off PS (achieving enteral autonomy), while no placebo-treated patients were able to discontinue PS. For patients treated with glepaglutide twice weekly, 14% of patients (n=5) achieved enteral autonomy. In total, 102 of 106 participating patients completed EASE-1, of which 96 continued into the ongoing two-year, long-term safety and efficacy extension trial, EASE-2. EASE-2 (NCT03905707) is a randomized, double-blind trial in which SBS patients continued their randomly assigned treatment from EASE-1 with glepaglutide 10 mg once- or twice-weekly. Patients who received placebo in EASE-1 were re-randomized to treatment with either glepaglutide 10 mg once- or twice-weekly. In an interim analysis conducted after at least six months of treatment, clinical response to glepaglutide across the key efficacy endpoints was generally maintained or showed continued improvement, including additional patients on both doses weaning off PS. Patients who complete EASE-2 are eligible to participate in EASE-3 (NCT04881825), evaluating glepaglutide administered once weekly using an autoinjector. An interim analysis of EASE-3, conducted with the first 57 patients rolled over from EASE 2, showed that the reduction in prescribed PS was generally maintained. EASE-4 (NCT04991311) was a Phase 3b trial to assess mechanistic effects of glepaglutide on intestinal fluid and energy uptake. The trial provides evidence of the pharmacodynamic effects of glepaglutide in improving intestinal absorption. In the second half of 2025, Zealand Pharma expects to initiate EASE-5, a single Phase 3 clinical trial that is anticipated to provide further confirmatory evidence for a regulatory submission in the U.S. About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) ('Zealand') is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products. Zealand was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the United States. For more information about Zealand's business and activities, please visit Forward looking statements This press release contains 'forward-looking statements', as that term is defined in the Private Securities Litigation Reform Act of 1995 in the United States, as amended, even though no longer listed in the United States this is used as a definition to provide Zealand Pharma's expectations or forecasts of future events regarding the research, development and commercialization of pharmaceutical products, the timing of the company's pre-clinical and clinical trials and the reporting of data therefrom. These forward-looking statements may be identified by words such as 'aim,' 'anticipate,' 'believe,' 'could,' 'estimate,' 'expect,' 'forecast,' 'goal,' 'intend,' 'may,' 'plan,' 'possible,' 'potential,' 'will,' 'would' and other words and terms of similar meaning. You should not place undue reliance on these statements, or the scientific data presented. The reader is cautioned not to rely on these forward-looking statements. Such forward-looking statements are subject to risks, uncertainties and inaccurate assumptions, which may cause actual results to differ materially from expectations set forth herein and may cause any or all of such forward-looking statements to be incorrect, and which include, but are not limited to, unexpected costs or delays in clinical trials and other development activities due to adverse safety events, patient recruitment or otherwise; unexpected concerns that may arise from additional data, analysis or results obtained during clinical trials; our ability to successfully market both new and existing products; changes in reimbursement rules and governmental laws and related interpretation thereof; government-mandated or market-driven price decreases for our products; introduction of competing products; production problems at third party manufacturers; dependency on third parties, for instance contract research or development organizations; unexpected growth in costs and expenses; our ability to affect the strategic reorganization of our businesses in the manner planned; failure to protect and enforce our data, intellectual property and other proprietary rights and uncertainties relating to intellectual property claims and challenges; regulatory authorities may require additional information or further studies, or may reject, fail to approve or may delay approval of our drug candidates or expansion of product labeling; failure to obtain regulatory approvals in other jurisdictions; exposure to product liability and other claims; interest rate and currency exchange rate fluctuations; unexpected contract breaches or terminations; inflationary pressures on the global economy; and political uncertainty. If any or all of such forward-looking statements prove to be incorrect, our actual results could differ materially and adversely from those anticipated or implied by such statements. The foregoing sets forth many, but not all, of the factors that could cause actual results to differ from our expectations in any forward-looking statement. All such forward-looking statements speak only as of the date of this company announcement and are based on information available to Zealand Pharma as of the date of this announcement. We do not undertake to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. Information concerning pharmaceuticals (including compounds under development) contained within this material is not intended as advertising or medical advice. Contacts Adam Lange (Investors) Vice President, Investor Relations [email protected] Neshat Ahmadi (Investors) Investor Relations Manager [email protected] Anna Krassowska, PhD (Investors and Media) Vice President, Investor Relations & Corporate Communications [email protected]

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store